Nephrolithiasis is a rare finding in kidney transplantation and anuria could be the only clinical sign. We report the case of a 52-year-old Caucasian male renal transplant recipient admitted due to acute renal failure (ARF) and anuria. He reported no symptoms and a palpable bulge in the right iliac fossa corresponding to the graft was present. Ultrasonography showed hydronephrosis of the graft. A double-J ureteral stent was inserted with resolution of ARF. ARF with anuria and the presence of a palpable non-tender, elastic mass over the graft could be the clinical picture of obstructive ARF in a transplanted kidney.

1.
Berger PM, Diamond JR: Ureteral obstruction as a complication of renal transplantation: a review. J Nephrol 1998;11:20–23.
2.
Benoit G, Blanchet P, Eschwege P, Jardin A, Charpentier B: Occurrence and treatment of kidney graft lithiasis in a series of 1,500 patients. Clin Transplant 1996;10:176–180.
3.
Hayes JM, Streem SB, Graneto D, Hodge EE, Steinmuller DR, Novick AC: Renal transplant calculi. A reevaluation of risks and management. Transplantation 1989;47:949–952.
4.
Hess B, Metzger RM, Ackermann D, Montandon A, Jaeger P: Infection-induced stone formation in a renal allograft. Am J Kidney Dis 1994;24:868–872.
5.
Greif F, Dreznick Z, Jacob ET: Calculus in 16-year-old cadaveric kidney transplant: A unique case and literature review. Nephron 1990;55:423–428.
6.
Olsson CA, Idelson B: Renal autotransplantation for recurrent renal colic. J Urol 1980;123:467–474.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.